DEDaniel Obinna Eke

Daniel Obinna Eke

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daniel Obinna Eke has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Social Media Use and Depression and Anxiety in Adolescents: A Global Systematic Review and Meta-Analysis

    by John Kelenna Iregbu, Hashim Iyiola Oyebamiji, Daniel Obinna Eke, Heidi Heather Henry Heimbruch, Samuel Z Kidane, Uchenna Ugochukwu Ozoekwe

    Background: Social media use among young people has risen sharply, and concern about its relationship to mental health is widespread. The evidence base remains heterogeneous in effect size, measurement, and design. Objective: To estimate the association between social media use and depressive and anxiety symptoms among adolescents and young adults, and to test whether the two differ. Methods: Four databases were searched from January 2010 to April 2021. Eligible studies reported a quantitative association between a social media exposure and a validated depression or anxiety measure. Stress subscales were not treated as anxiety outcomes. Effect sizes were pooled as Pearson correlations using random-effects models. Results: The pooled association with depressive symptoms was r = 0.263 (95% CI: 0.200-0.324; k = 10; N = 5,774; I² = 83.9%), prediction interval 0.031-0.468. For anxiety it was r = 0.363 (95% CI: 0.265-0.453; k = 7; N = 5,286; I² = 93.3%), prediction interval −0.009-0.646. A paired comparison across the five samples contributing to both outcomes found no difference (p = .77). Mean sample age predicted the depression association (b = 0.045 per year; p = .023) and accounted for almost all heterogeneity. Restricting to samples with mean age below 19 reduced the depression estimate to r = 0.196. Conclusions: Social media use is positively associated with depressive and anxiety symptoms, at a small-to-moderate magnitude and with no detectable difference between outcomes. The anxiety prediction interval includes zero, and the association is weaker in adolescent samples. The cross-sectional evidence precludes causal inference. Keywords: Social Media; Depression; Anxiety; Adolescents; Young Adults; Meta-Analysis; Internalizing Symptoms


  • Open Access

    From Microscopy to Precision Hematology: The Evolution of Artificial Intelligence in Hematologic Diagnostics

    by Chidinma Lorretta Gab-Obinna, Daniel Obinna Eke, Jane Ifeyinwa Anatuanya, Blessing Nwakaego Enenmoh.

    Hematologic diagnostics has evolved considerably over the past decades, progressing from reliance on manual microscopic examination to increasingly sophisticated digital and artificial intelligence (AI)-enabled diagnostic systems. This transformation has been driven by the growing complexity of hematologic diseases, advances in molecular medicine, and the need for faster, more standardized, and more reproducible diagnostic approaches. AI has emerged as a transformative technology capable of enhancing image interpretation, automating routine laboratory processes, and integrating diverse sources of diagnostic information to support precision medicine. This narrative review critically examines the evolution of hematologic diagnostics from conventional microscopy to AI-assisted practice and explores how AI is reshaping diagnostic workflows across the hematologic diagnostic pathway. Current evidence indicates that AI has substantially improved blood smear analysis, bone marrow evaluation, disease detection and classification, and clinical decision support while reducing observer variability and improving laboratory efficiency. Moreover, the integration of morphology with flow cytometry, cytogenetics, genomics, laboratory findings, and clinical metadata is redefining hematologic diagnosis as a multidimensional, patient-centered process. Despite these advances, important challenges remain, including limited external validation, dataset heterogeneity, algorithm transparency, interoperability, regulatory oversight, and equitable implementation across diverse healthcare settings. The review further identifies key evidence gaps and proposes the Precision Hematology Evolution Framework (PHEF) as a conceptual model illustrating the transition from morphology-based diagnosis to AI-enabled precision hematology. Collectively, the evidence suggests that AI is best viewed as an enabling technology that augments expert clinical interpretation rather than replacing it. Continued multidisciplinary collaboration, rigorous validation, and responsible governance will be essential to fully realize the promise of AI in delivering more accurate, personalized, and equitable hematologic care.

  • Open Access

    Generative AI-Induced Psychosis and Its Public Health Implications: A Scoping Review

    by Heidi Heather Henry Heimbruch, Daniel Obinna Eke, Lauren Henry, Reuben Adelala Aragbaye

    The rapid advancement and widespread adoption of generative artificial intelligence (AI), particularly large language models (LLMs) and conversational AI systems, have transformed digital mental healthcare by improving access to information, clinical decision support, and psychological assistance. However, increasing concerns have emerged regarding their potential to contribute to adverse psychiatric outcomes, including psychosis, particularly among vulnerable individuals. This scoping review mapped the current evidence on generative AI-induced psychosis and examined its implications for public health. The review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) and the Joanna Briggs Institute (JBI) methodology. Searches of Google Scholar, PubMed, Scopus, SpringerLink, and ScienceDirect identified 1,876 records, of which 21 studies met the inclusion criteria and were included in the final synthesis. The evidence indicates that generative AI has considerable potential to enhance psychiatric assessment, clinical decision-making, emotional support, and access to mental health services. At the same time, emerging risks include the reinforcement of delusional beliefs, hallucination-like experiences, reality distortion, misinformation, emotional dependency, and the exacerbation of psychotic symptoms, particularly among individuals with pre-existing psychological vulnerabilities. Ethical concerns relating to privacy, algorithmic bias, digital inequality, and the absence of comprehensive regulatory frameworks were also consistently reported. Although the current evidence remains limited and largely exploratory, the findings underscore the need for responsible AI governance, robust clinical oversight, multidisciplinary collaboration, and longitudinal research to better understand and mitigate the long-term mental health consequences of generative AI.

  • CRISPR-Cas9 in Human Health: A Scoping Review of Therapeutic Applications, Safety Challenges, and Ethical Frameworks

    by Muhydeen Damilola Badru, Verity Ghansah, Ifeoluwa Oyinkansola Adesanya, Joseph David, Nkemdilim Clairelouise Okechukwu, Daniel Obinna Eke

    Background: CRISPR-Cas9 has revolutionized genome editing by providing an efficient, versatile, and comparatively accessible platform for targeted genetic modification. Its rapid progression from laboratory innovation to clinical application has generated substantial interest across multiple therapeutic domains, while simultaneously raising significant safety, ethical, and regulatory concerns. Objective: This scoping review aimed to comprehensively map current evidence regarding the therapeutic applications, safety challenges, and ethical frameworks associated with CRISPR-Cas9 in human health. Methods: A scoping review methodology guided by the Arksey and O’Malley framework and PRISMA-ScR guidelines was employed. Comprehensive searches were conducted across PubMed, Dimensions, and Embase for peer-reviewed English-language studies published between 2015 and 2026. Eligible studies focused on CRISPR-Cas9 applications in human health, including therapeutic interventions, safety evaluations, ethical analyses, and regulatory considerations. A total of 32 studies met the inclusion criteria and underwent thematic synthesis. Results: CRISPR-Cas9 demonstrated substantial therapeutic promise across hematologic disorders, metabolic diseases, ophthalmologic conditions, oncology, immunotherapy, and rare genetic disorders. The most clinically advanced applications were observed in sickle cell disease, β-thalassemia, hereditary transthyretin amyloidosis, and hereditary angioedema, where clinical trials showed durable and potentially curative outcomes. However, major barriers remain, including off-target effects, genomic instability, delivery inefficiencies, immunogenicity, and limited long-term safety data. Ethical and regulatory concerns were prominent, particularly regarding germline editing, health equity, global governance, and accessibility. Conclusion: CRISPR-Cas9 has demonstrated considerable clinical potential across a range of therapeutic applications, particularly for selected monogenic disorders in which the strongest clinical evidence is currently available. Although important advances have been achieved, broader clinical implementation will require continued improvements in editing precision, long-term safety evaluation, delivery technologies, ethical oversight, equitable access, and harmonized regulatory frameworks.

  • Open Access

    Autonomous Medical Documentation Pipelines: Integrating Large Language Models and Cloud Speech Services to Reduce Clinician Administrative Burden and EHR Workflow Bottlenecks

    by Heidi Heather Henry Heimbruch, Williams Temidayo Solomon, Salamah Abimbola Junaid, Daniel Obinna Eke, Leo Tata, Olaitan Ebenezer Oluwadare, Habib Shehu

    Background: Autonomous medical documentation has become a central challenge in modern healthcare, as clinicians increasingly spend substantial portions of their workday on electronic health record (EHR) tasks rather than direct patient care, contributing to dissatisfaction, burnout, and workflow inefficiencies. Large language models (LLMs) and cloud-based speech services offer a potential solution by automating aspects of note generation, structured documentation, and coding support while preserving clinician oversight. Objectives: To map and characterize the emerging evidence on autonomous or semi-autonomous documentation pipelines that integrate LLMs, cloud speech services, and EHR workflows, focusing on technical architecture, workflow integration, safety, governance, and clinician experience. Methodology: A systematic search of PubMed, ACM Digital Library, and Dimensions AI was conducted for studies published from 2019 to March 2026, supplemented by reports and policy documents. Eligible studies included empirical research, reviews, and implementation reports addressing documentation efficiency, accuracy, and clinician outcomes. Findings: Evidence indicates that layered pipelines combining speech processing, LLM-driven note generation, retrieval of structured EHR data, and FHIR-based integration can reduce documentation time, decrease after-hours charting, improve note quality, and enhance clinician satisfaction. Human oversight remains essential to mitigate risks from hallucination, transcription errors, and workflow misalignment. Governance, consent, and data security are critical for safe adoption. Conclusion: Overall, autonomous documentation pipelines are most effective when implemented as assisted automation tools embedded within context-sensitive clinical workflows, with iterative evaluation and robust governance. These insights provide a foundation for future research, clinical validation, and scalable deployment strategies.

  • Digital Mental Health Interventions for Depression and Anxiety in Youth: A Scoping Review of Effectiveness, Engagement, and Implementation

    by Heidi Heather Henry, Anthony Onyebuchi Onwudiwe, Susan Ayobami Ogundare, Daniel Obinna Eke

    Depression and anxiety are among the most prevalent mental health conditions affecting children, adolescents, and young people, contributing substantially to the global burden of disease. Despite the availability of effective treatments, access to care remains limited due to structural, economic, and stigma-related barriers, particularly in low-resource settings. Digital mental health interventions have emerged as a scalable and accessible approach to addressing these gaps. This scoping review aimed to map the extent, range, and characteristics of existing evidence on digital interventions targeting depression and anxiety in individuals aged approximately 10–24 years, with a focus on effectiveness, engagement, and implementation. A systematic search of PubMed, Dimensions, and CINAHL was conducted, and primary studies of any design published in English were included. Data were extracted and synthesized using descriptive and thematic approaches. A total of 42 studies were included, covering diverse modalities such as internet-based cognitive behavioral therapy, mobile applications, chatbots, and tele-mental health platforms. Digital interventions were associated with reductions in depressive and anxiety symptoms, particularly in the short term. However, between-group effects were often modest when compared with active controls. Engagement emerged as a key determinant of effectiveness, with higher adherence linked to better outcomes. While feasibility and acceptability were generally high, challenges related to sustained engagement and long-term effectiveness were common. Digital interventions show promise as adjuncts to conventional care but require further optimization and evaluation in real-world settings.

  • Cancer-Specific Disproportionality Signals Associated with Metformin Versus Other Antidiabetic Agents: A Real-World Pharmacovigilance Analysis of FAERS

    by Daniel Obinna Eke, Jessica Awingosit Ayamyiya, Katabaazi Lillian Mirembe, Anthony Kosisochukwu Anyabuoke, Gloria Oluwabukunmi Oladapo

    Type 2 diabetes mellitus is associated with an increased risk of several malignancies, prompting interest in the potential oncologic effects of antidiabetic therapies, particularly metformin. This study evaluated cancer-related adverse event reporting associated with metformin compared with other antidiabetic agents using real-world pharmacovigilance data from the FDA Adverse Event Reporting System (FAERS) between Q1 2023 and Q4 2024. A disproportionality analysis was conducted on over 3.2 million reports, including 66,187 metformin cases and 55,257 comparator cases comprising GLP-1 receptor agonists, SGLT2 inhibitors, sulfonylureas, and insulin. Reporting odds ratios (ROR), proportional reporting ratios (PRR), information components (IC), and chi-squared tests were applied across twelve pre-specified cancer types. Metformin was associated with significantly lower reporting of hepatocellular carcinoma (ROR 0.377, 95% CI 0.181–0.782) and pancreatic carcinoma (ROR 0.669, 95% CI 0.493–0.908). In contrast, increased reporting signals were observed for prostate cancer (ROR 2.065, 95% CI 1.435–2.972), leukaemia (ROR 2.388, 95% CI 1.155–4.939), and breast cancer (ROR 1.404, 95% CI 1.023–1.926). Drug-specific comparisons indicated relatively lower overall cancer reporting for metformin compared with sitagliptin and empagliflozin, but higher reporting compared with insulin. Temporal analyses demonstrated variability in reporting patterns across study quarters. These findings represent disproportionality signals reflecting reporting associations rather than causal effects and may be influenced by reporting bias, residual confounding, and differences in healthcare utilization. Overall, the results suggest a heterogeneous, cancer-type-specific reporting profile for metformin and highlight the value of pharmacovigilance analyses in generating real-world safety signals. Further confirmation in prospective and mechanistic studies is required.

  • Integrating Social Determinants of Health into Precision Medicine: A Critical Review of a Missing Link in Personalized Healthcare

    by Daniel Obinna Eke, Chidinma Lorretta Gab-Obinna, Victor Ibiam, Isaac Baiden, Akinlolu Oluwamisimi, Ndidi Atasie Eboh

    Background: Precision medicine has transformed healthcare through advances in genomics, biomarkers, and artificial intelligence. However, its predominant focus on biological determinants reflects a reductionist approach that inadequately captures the broader social and environmental factors influencing health outcomes. Aim: This review aims to critically examine the limitations of current precision medicine frameworks, particularly the exclusion of social determinants of health (SDOH), and to explore the need for a more integrative, context-aware approach to personalized healthcare. Methods: A critical narrative review was conducted using literature from PubMed, Scopus, and Web of Science, covering publications between 2015 and 2025. Relevant studies addressing precision medicine, SDOH, health disparities, and artificial intelligence were selected based on predefined inclusion criteria and analyzed using thematic synthesis. Results: The findings reveal that current precision medicine models are constrained by biological reductionism, data bias, algorithmic inequities, and fragmented data systems. The exclusion of SDOH limits predictive accuracy, reduces the effectiveness of personalized interventions, and contributes to persistent health disparities. Emerging evidence highlights the potential of integrating artificial intelligence and digital health technologies with social and behavioral data to enhance context-aware care. Conclusion: Precision medicine, as currently practiced, is biologically precise but contextually incomplete. Integrating SDOH into precision medicine frameworks is essential for improving clinical effectiveness, promoting health equity, and ensuring real-world applicability. A shift toward an integrative model that combines biological, social, and behavioral determinants is necessary to achieve truly personalized and patient-centered healthcare.

  • Anorectoplasty for Anorectal Malformations: Surgical Outcomes, Predictive Factors for Continence and Quality of Life

    by Daniel Obinna Eke, Chidinma Lorretta Gab-Obinna, Oforbuike Samuel Odo, Chinedu Nwosu-Ijiomah

    Anorectal malformations (ARMs) are a heterogeneous group of congenital anomalies involving abnormal development of the distal rectum and anus, frequently accompanied by fistulous connections and associated urogenital or spinal defects. Despite major advances in pediatric colorectal surgery, achieving satisfactory long-term outcomes remains challenging, particularly in relation to fecal continence, postoperative complications, and psychosocial well-being. This review aimed to synthesize recent evidence on the surgical outcomes of anorectoplasty techniques, the predictive factors associated with postoperative continence, and the long-term impact of treatment on quality of life. A narrative review approach was adopted. Literature was searched across PubMed, ScienceDirect, and Dimensions AI, focusing on studies published between 2021 and 2025. Following screening and eligibility assessment, 13 studies were included in the final synthesis. Evidence from the reviewed studies indicates that posterior sagittal anorectoplasty (PSARP) remains the standard surgical technique for many ARM subtypes because of its strong anatomical visualization and broad applicability. Minimally invasive approaches, including laparoscopic-assisted anorectoplasty (LAARP) and robotic-assisted anorectoplasty (RAARP), appear promising, particularly in selected complex cases, with potential advantages such as reduced postoperative pain, shorter recovery time, improved cosmetic outcomes, and enhanced operative precision. However, long-term evidence for these newer techniques remains limited. Across the included studies, continence outcomes were influenced by multiple factors, including age at surgery, malformation type, sacral development, sphincter integrity, and associated anomalies. High-type malformations were consistently associated with less favorable functional outcomes than low-type malformations. In addition, quality of life after repair was shaped not only by continence status and bowel function but also by psychosocial adjustment, stigma, and access to multidisciplinary follow-up care. Overall, the findings highlight the importance of early intervention, individualized surgical planning, structured long-term bowel management, and coordinated multidisciplinary care. Further multicenter prospective studies are needed to strengthen comparative evidence and improve lifelong outcomes for patients with anorectal malformations.